You do not currently have permission to view the full text for this document. Please sign in to an account with an active subscription or contact support.
From menarche to menopause, women are highly vulnerable to major depression. While biological and psychosocial differences between men and women have been established, the reason for the preponderance of depression in women has yet to be fully elucidated. Women may be predisposed to depressive illness because of biological factors related to brain structure, function, and the impact of reproductive life stages. They may also be at increased risk because they are differentially disadvantaged with respect to environmental stressors including interpersonal violence, socioeconomic instability, and care-giving burden, among others. However, not all women develop depression, nor do all individuals who suffer from adverse life events. This narrative review focuses on emerging research related to the interaction between sex, genetics, and environmental factors that may help offer clues about why some individuals suffer from depression, and why others may be resilient to this outcome. While many questions remain unanswered, the psychodynamic psychotherapist can use this information to help patients suffering from depression understand some of the complexities of the determinants of risk and resilience, with the goal of moving forward toward recovery.
Simone N. Vigod, M.D., M.Sc., FRCPC and Valerie H. Taylor, M.D., Ph.D., FRCPC, Women's College Hospital and Women's College Research Institute, Toronto, Ontario; University of Toronto, Toronto, Ontario.
Funding Source: This work was not supported by any funding agency.
Financial Disclosure: No authors received payments for their efforts on this project. Unrelated to this project, Dr. Vigod has received a one-time consulting fee from Multi-Dimensional Health Care (MDH) consulting for the development of continuing health care activities related to perinatal mental health; Dr. Taylor receives funding from Bristol-Myers Squibb for an investigator initiated study and has been a speaker for Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, and Lundbeck.
Conflict of Interest: No authors have conflicts of interest to disclose and we declare no other relationships or activities that could appear to have influenced the submitted work.